All trading involves risk. Ensure you understand those risks before trading.
All trading involves risk. Ensure you understand those risks before trading.

Bed Bath & Beyond Q1 preview: Where next for BBBY stock?

Article By: ,  Former Market Analyst

When will Bed Bath & Beyond release Q1 earnings?

Bed Bath & Beyond is scheduled to release first quarter earnings covering the three months to May 28 before US markets open on Wednesday June 29.

 

Bed Bath & Beyond Q1 earnings consensus

Sales are forecast to drop over 22% from last year in the first quarter to $1.5 billion. The company, a favourite with retail traders, is expected to turn to an adjusted Ebitda loss of $79 million compared to the $86 million profit reported the year before, and swing to an adjusted loss per share of $1.27. 

 

Bed Bath & Beyond Q1 earnings preview

It is expected to be another tough period for Bed Bath & Beyond when it releases first quarter earnings this week, as supply chain problems and inventory troubles threaten to thwart the homeware retailer’s multi-year turnaround programme.

President and CEO Mark Tritton conceded that the board was ‘disappointed’ by the company’s performance during the last financial year that ran until the end of February, as supply chain disruption, the Omicron variant and lower consumer confidence had revealed a number of vulnerabilities at a time when it is trying to rebuild the business.

Investors will be hoping inventory levels and transit times have improved as this was a key headwind that held back sales by some $175 million and caused margins to contract in the previous quarter. It warned that it has been struggling to get its hands on the inventory it needs and said this would remain a problem ‘into the early part of fiscal 2022’. It is taking much longer to ship goods to where they need to be, and Bed Bath & Beyond said the amount of inventory stuck at congested ports was ‘abnormally high’.

Bed Bath & Beyond has already warned that the first half of the financial year will be tougher than the second as a result, assuming the supply chain problems ease later in 2022. This should also allow it to modestly improve its adjusted gross margin over the full year as a result and see adjusted Ebitda start to improve on year-on-year basis in the second half.

Sales were already in decline before these challenges emerged as it has divested several non-core brands as part of its transformation. The buybuy Baby brand is still delivering low-single digit growth in sales and providing some encouragement at a time when sales of its core products such as bedding, home décor, bath and kitchen products are in decline.

Still, Bed Bath & Beyond has continued to generate cash and has returned some of that to investors through share buybacks. The company had some $500 million in cash and investments at the end of February and total liquidity of around $1.4 billion, and that should improve as cashflow recovers when the kinks in the supply chain are ironed out. Wall Street currently believes operating cashflow will steadily increase throughout this year and rise by over one-third annually.

 

Where next for BBBY stock?

Bed Bath & Beyond shares have collapsed over 75% over the last three months but appear to have found a floor after hitting a 13-month low of $5.95 earlier in June, which pushed the RSI into oversold territory to suggest this is the initial level of resistance that needs to hold. A slip below here opens the door to levels last seen when the stock bottomed-out from the pandemic-induced falls seen back in April 2020, first to $5.90 and then to $5.25. The ultimate floor should be considered as $4.40.

The stock has climbed over 13% since hitting that 13-month low, providing some confidence it can head higher. The first upside target for the stock is the May-low of $7.50 which, once recaptured, opens the door to $9.66 and then the 50-day moving average at $10.65.  Notably, the 19 brokers that cover the stock see mild upside from current levels with an average target price of $7.23.

 

How to trade Bed Bath and Beyond stock

You can trade Bed Bath & Beyond shares with City Index in just four easy steps:

  1. Open a City Index account, or log-in if you’re already a customer.
  2. Search for ‘BBBY’ in our award-winning platform
  3. Choose your position and size, and your stop and limit levels
  4. Place the trade

Or you can try out your trading strategy risk-free by signing up for our Demo Trading Account.

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.

City Index is a trading name of StoneX Financial Pty Ltd.

The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.

While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.

StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment further CFD investors do not own or have any rights to the underlying assets.

It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.cityindex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.cityindex.com/en-au/terms-and-policies/.

StoneX Financial Pty Ltd, Suite 28.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.

© City Index 2024